After extensive conversations over the past
several weeks with senior staff persons and
key Members of Congress who serve on the congressional committees with
jurisdiction over the bill, it has become clear that very few, if any, public health bills such as the SMA Treatment Acceleration Act will move through Congress during the lame - duck session set to begin on November 15.